Shiyu Capital operates as an equity investment and asset management institution.
Business Model:
Revenue: $0
Employees: 0-0
Address: Room 1006-1008, West Tower, Kailu Building, No. 8 Xinyuan South Road
City: Beijing
State: beijing municipality
Zip: -
Country: CN
Shenzhen Shiyu Investment Management Co.,Ltd.(SHIYU or the Company )is a professional equity investment and asset management institution, focusing on equity investment in pharmaceutical and healthcare industry, asset allocation and wealth management.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2017 | PhiSkin | Series B | 17.7M |
2/2021 | WuXi Diagnostics | Series B | 0 |
6/2019 | Biotheus | Seed Round | 14.5M |
11/2020 | CARsgen Therapeutics | Series C | 0 |
3/2021 | OnQuality | Series A | 20M |
5/2020 | Novast | Venture Round | 0 |
4/2015 | JYC99.com | Angel Round | 484.1k |
3/2021 | Biotheus | Equity | 100M |
8/2018 | GloriousMed Technology | Series A | 11M |
3/2021 | Biotheus | Series B | - |
5/2019 | Allist Pharmaceuticals | Series A | 173.9M |
2/2019 | Sciwind Biosciences | Series A | 29.6M |
3/2021 | OnQuality Pharmaceuticals | Series A | 0 |
3/2021 | QnQuality Pharmaceuticals | Series A | 0 |
4/2020 | Mabwell Biotech | Series A | 0 |
7/2019 | Lepu Bio | Series A | 0 |
12/2018 | Crystal Pharmatech | Series A | 14.5M |
3/2021 | OnQuality Pharmaceuticals | Series A | 0 |
3/2021 | QnQuality Pharmaceuticals | Series A | 0 |
3/2021 | Biotheus | Series B | - |
3/2021 | Biotheus | Series D | 0 |
2/2021 | WuXi Diagnostics | Series B | 0 |
11/2020 | CARsgen Therapeutics | Series C | 0 |
5/2020 | Novast | Venture Round | 0 |
4/2020 | Mabwell Biotech | Series A | 0 |
7/2019 | Lepu Bio | Series A | 0 |
6/2019 | Biotheus | Seed Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|